0

Infectious Disease Diagnostics Market Expected to Reach $39.941 Billion by 2030

 
2022
Infectious Disease Diagnostics Market

Report Code : A01681

quote Alarming rise in prevalence of infectious diseases, advancements in diagnostic instruments, rise in government &private funds for development of healthcare sectors, and increase in awareness about early diagnosis are expected to notably contribute toward the growth of the global infectious disease diagnostic market during the forecast period. quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, Infectious Disease Diagnostic Market by Product, Disease Type, and Technology: Global Opportunity Analysis and Industry Forecast, 2021–2030,"the global infectious disease diagnostic market was valued at $23.321 billion in 2020, and is estimated to reach $39.941 billion by 2030, growing at a CAGR of 6.8% from 2021 to 2030.

An infectious disease is any disorder that is caused by various microorganisms such as viruses, bacteria, fungi, or parasite. Hepatitis, human immunodeficient virus (HIV), healthcare-associated infection, surgical site infection, pneumonia, influenza, and COVID-19 are some of most prevalent infectious diseases across the globe. Infectious disease diagnostics involves procedures to detect and identify the causative organism for appropriate treatment and management of infectious diseases. The most common diagnostic tests for infectious diseases are laboratory tests, imaging scans, and biopsies. Other advanced diagnostic tests for detection of infectious diseases are immunochromatographic tests, point-of-care diagnostic tests, and next-generation sequencing test.

The factors that drive the growth of the global infectious disease diagnostic market include increase in the number of diagnostic laboratories, advancements in diagnostic instruments, and surge in demand for point-of-care diagnostic tests. In addition, rise in prevalence of infectious diseases such as hepatitis, pneumonia, HIV, healthcare-associated infection, & COVID-19 notably contributes toward the growth of the global market. According to the World Health Organization, in 2020, approximately 325 million individuals in the world were reported to be diagnosed with hepatitis. As per the same source, in 2019, approximately 290 million individuals in the world died from hepatitis C. Furthermore, market players are focused on the development of advanced diagnostic devices for detection of infectious diseases. For instance, in 2020, Becton, Dickinson and Company, one of the leading medical technology companies, launched a rapid point-of-care antigen test to detect COVID-19 in 15 minutes. Furthermore, in 2021, Thermo Fisher Scientific, the world leader in serving science, launched MAS Omni infectious disease quality controls sets for monitoring the serological assays for organism such as hepatitis B&C virus and HIV 1&2 virus.

Moreover, rise in disposable income, and improvement in healthcare safety standard are anticipated to drive the growth of infectious disease diagnostic market. In addition, increase in demand for effective, fast, and accurate diagnostic result has led to the development of innovative technologies in the healthcare sector, thereby propelling the growth of the market.

Moreover, initiatives taken by governments for development of the advanced diagnostic centers and increase in number of medical laboratories are the key factors that boost the growth of the market. Furthermore, development of the healthcare sector and surge in geriatric population, who are more vulnerable to infectious disease propel the growth of the market. In addition, increase in demand for point-of-care testing and surge in awareness of early diagnosis of infectious diseases fuel the market growth.

The global infectious disease diagnostic market is segmented on the basis of product, disease type, technology, and region. On the basis of product, the market is divided into assays & reagents, instruments, and software. The assays & reagents segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to advancement in R&D activities in pharmaceutical & biotechnology industry, increase in demand for reagents, and surge in adoption of point-of-care testing.

Depending on disease type, the market is classified into hepatitis, human immunodeficiency virus (HIV), influenza, and others. The other segment exhibited the highest growth in 2020, and this trend is expected to continue during the forecast period, owing to increase in incidence of infectious disease cases, high testing volumes, and stringent government regulations to develop advanced medical devices. By technology, the market is classified into immunodiagnostics, clinical microbiology, polymerase chain reaction (PCR), next-generation sequencing, and others. The others segment acquired the top position in the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in demand for DNA analysis, development of novel & innovative medical diagnostic tools, and advancement in R&D activities for infectious disease diagnosis.

The COVID-19 outbreak is anticipated to have a positive impact on the growth of the global infectious disease diagnostic market. The COVID-19 pandemic has stressed the healthcare systems in the world and increased the need for the development of diagnostic instruments & diagnostic service centers. Increase in number of COVID-19 cases surged the demand for real time polymerase chain reaction (RT-PCR) test to detect COVID-19. For instance, in 2020, the U.S. Food and Drug Administration authorized an antigen test that is the first over-the-counter fully at-home diagnostic test used for detection of COVID-19.

Moreover, in 2020, a total of 646 government laboratories and 247 private laboratories reported to Indian Council of Medical Research (ICMR) for COVID testing. Furthermore, in 2020, the World Health Organization, the Africa Centers for Disease Control and Prevention, the foundation for innovative new diagnostics, the global fund, and the Bill & Melinda Gates foundation announced the partnership to provide 120 million affordable quality COVID-19 rapid tests for low and middle income countries. This has significantly contributed toward the growth of the global market.

Key Findings Of The Study

  • By product, the assays & reagents segment was the highest contributor to the infectious disease diagnostic market in 2020.
  • On the basis of disease type, the others segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
  • Depending on technology, the others segment was the highest contributor to the market in 2020.
  • Region wise, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

North America accounted for a majority of the global infectious disease diagnostic market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of infectious diseases, presence of key players, development of the healthcare sector, presence of national clinical laboratories, and advancement in technology for diagnostic instruments in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in prevalence of infectious diseases, a rise in the demand for early diagnosis, improvement in healthcare infrastructure, and technological advancements in diagnostic testing

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Infectious Disease Diagnostic Market by Product (Assays & Reagents, Instruments, and Software), Disease Type (Hepatitis, Human Immunodeficiency Virus, Influenza, and Others), and Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next Generation Sequencing, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Mar 2024

Hairbrush Market

Download Sample
rep-img

Published Date Mar 2024

Debt Security Market

Download Sample
rep-img

Published Date Mar 2024

Wood Adhesives Market

Download Sample

Buy Full Version
"Infectious Disease Diagnostics Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers